Basic Information
| LncRNA/CircRNA Name | circARSP91 |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | natural killer cell | Survival | ||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular cancer |
| ICD-0-3 | NA |
| Methods | qPCR |
| Sample | HCC cell lines |
| Expression Pattern | differential expressed |
| Function Description | In conclusion, CircARSP91 could enhance innate immune surveillance by strengthening the cytotoxicity of NK cells, implying that circRNA may serve a role in tumor immunity. |
| Pubmed ID | 30655779 |
| Year | 2019 |
| Title | circRNA of AR-suppressed PABPC1 91 bp enhances the cytotoxicity of natural killer cells against hepatocellular carcinoma via upregulating UL16 binding protein 1. |
External Links
| Links for circARSP91 | GenBank HGNC NONCODE |
| Links for hepatocellular cancer | OMIM COSMIC |